Roivant Sciences Ltd (ROIV)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $28.64B
Last updated: Nov 17, 2026 at 4:15 PM ET
Roivant Sciences Ltd (ROIV) Stock Chart
Roivant Sciences (ROIV) has a latest price of $38.71 on Nov 17, 2026, 8.9% below its 52-week high of $42.50. Its price rose 90.8% over the past 12 months. The month-end price rose 364.9% over the 5 years through Oct 2026, a compound annual rate of 36.0%.
Price Chart
From Oct 2021 to Oct 2026, its highest month-end close was $36.91 in Oct 2026 and its lowest $3.22 in Sep 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ROIV with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ROIV.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 3.5%, and over 6 months it rose 37.2%. The month-end price rose 327.2% over the 3 years through Oct 2026, a compound annual rate of 62.3%.
| Period | Change |
|---|---|
| 1 month | +11.6% |
| 3 months | +3.5% |
| 6 months | +37.2% |
| 12 months | +90.8% |
| 12 months, with dividends | +90.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +327.2% | +62.3% |
| 5 years | +364.9% | +36.0% |
Price by Year
Its best calendar year was 2025, when the price rose 83.4%, and its weakest was 2022, when it fell 20.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $36.91 | +70.1% |
| 2025 | $21.70 | +83.4% |
| 2024 | $11.83 | +5.3% |
| 2023 | $11.23 | +40.6% |
| 2022 | $7.99 | -20.7% |
Trading Range
The price is 3.7% above its 50-day average of $37.32 and 19.2% above its 200-day average of $32.48.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $38.71 | |
| 52-week high | $42.50 | -8.9% |
| 52-week low | $19.96 | +93.9% |
| 50-day average | $37.32 | +3.7% |
| 200-day average | $32.48 | +19.2% |
Price Risk
Over 3 years, its largest fall from a peak was 28.6%.
| Measure | Value |
|---|---|
| 1-year beta | 1.12 |
| Largest fall, 1 year | -20.2% |
| Largest fall, 3 years | -28.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ROIV
What is ROIV's 1-year price change?
Roivant Sciences's price rose 90.8% over the past 12 months. With dividends included, the 12-month total return was 90.8%.
What is ROIV's 5-year price change?
Roivant Sciences's month-end price rose 364.9% over the 5 years through Oct 2026, a compound annual rate of 36.0%. These figures leave out dividends.
What is ROIV's 52-week high and low?
Roivant Sciences's 52-week high is $42.50 and its 52-week low is $19.96. Its latest price of $38.71 on Nov 17, 2026 is 8.9% below the high.
What is ROIV's beta?
Roivant Sciences's 1-year beta against the S&P 500 is 1.12, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 20.2%.
Is the ROIV chart free?
Yes. Advanced Charting for ROIV is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ROIV pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors